相似文献
1
Obstructive Sleep Apnea and the Liver.
Clin Liver Dis. 2019 May;23(2):363-382. doi: 10.1016/j.cld.2019.01.001.
2
Nonalcoholic fatty liver disease and obstructive sleep apnea.
Metabolism. 2016 Aug;65(8):1124-35. doi: 10.1016/j.metabol.2016.05.004. Epub 2016 May 13.
3
Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease.
Am J Respir Crit Care Med. 2019 Apr 1;199(7):830-841. doi: 10.1164/rccm.201806-1109TR.
4
Effect of CPAP therapy on liver disease in patients with OSA: a review.
Sleep Breath. 2018 Dec;22(4):963-972. doi: 10.1007/s11325-018-1622-x. Epub 2018 Jan 11.
5
Treating Obstructive Sleep Apnea and Chronic Intermittent Hypoxia Improves the Severity of Nonalcoholic Fatty Liver Disease in Children.
J Pediatr. 2018 Jul;198:67-75.e1. doi: 10.1016/j.jpeds.2018.03.028. Epub 2018 May 8.
6
Continuous Positive Airway Pressure Does Not Improve Nonalcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea. A Randomized Clinical Trial.
Am J Respir Crit Care Med. 2021 Feb 15;203(4):493-501. doi: 10.1164/rccm.202005-1868OC.
7
Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea.
J Clin Sleep Med. 2018 Aug 15;14(8):1315-1322. doi: 10.5664/jcsm.7262.
8
Association between continuous positive airway pressure and serum aminotransferases in patients with obstructive sleep apnea.
Eur Arch Otorhinolaryngol. 2018 Feb;275(2):587-594. doi: 10.1007/s00405-017-4840-0. Epub 2017 Dec 9.
9
Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials.
Respirology. 2016 Feb;21(2):378-85. doi: 10.1111/resp.12672. Epub 2015 Nov 16.
10
Association between non-alcoholic fatty liver disease and obstructive sleep apnea.
World J Gastroenterol. 2020 May 28;26(20):2669-2681. doi: 10.3748/wjg.v26.i20.2669.
引用本文的文献
1
The Triglyceride-Glucose Index Mediates the Association Between Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Disease: Findings From Two Cross-Sectional Datasets.
Diabetes Metab Syndr Obes. 2025 Aug 31;18:3111-3123. doi: 10.2147/DMSO.S526411. eCollection 2025.
2
Brain nitric oxide and inflammation in chronic intermittent hypoxia: Contributors to cognitive impairment and hypertension.
Brain Behav Immun Health. 2025 Aug 4;48:101077. doi: 10.1016/j.bbih.2025.101077. eCollection 2025 Oct.
3
Potential bidirectional communication between the liver and the central circadian clock in MASLD.
NPJ Metab Health Dis. 2025;3(1):15. doi: 10.1038/s44324-025-00058-1. Epub 2025 Apr 9.
4
Phenome-wide associations of sleep characteristics in the Human Phenotype Project.
Nat Med. 2025 Mar;31(3):1026-1037. doi: 10.1038/s41591-024-03481-x. Epub 2025 Jan 27.
5
IL6 Derived from Macrophages under Intermittent Hypoxia Exacerbates NAFLD by Promoting Ferroptosis via MARCH3-Led Ubiquitylation of GPX4.
Adv Sci (Weinh). 2024 Nov;11(41):e2402241. doi: 10.1002/advs.202402241. Epub 2024 Sep 4.
6
Association of Obstructive Sleep Apnea with Nonalcoholic Fatty Liver Disease: Evidence, Mechanism, and Treatment.
Nat Sci Sleep. 2024 Jul 8;16:917-933. doi: 10.2147/NSS.S468420. eCollection 2024.
7
Chronic Intermittent Hypoxia-Induced Dysmetabolism Is Associated with Hepatic Oxidative Stress, Mitochondrial Dysfunction and Inflammation.
Antioxidants (Basel). 2023 Oct 25;12(11):1910. doi: 10.3390/antiox12111910.
8
The impact of obstructive sleep apnea on nonalcoholic fatty liver disease.
Front Endocrinol (Lausanne). 2023 Oct 2;14:1254459. doi: 10.3389/fendo.2023.1254459. eCollection 2023.
9
Nonalcoholic liver disease: Epidemiology, risk factors, natural history, and management strategies.
Ann N Y Acad Sci. 2023 Aug;1526(1):16-29. doi: 10.1111/nyas.15012. Epub 2023 Jul 3.
10
and were correlated with adipose tissue macrophage infiltration and involved in obstructive sleep apnea related metabolic dysregulation: Evidence from bioinformatics analysis.
Front Genet. 2023 Feb 27;14:1128139. doi: 10.3389/fgene.2023.1128139. eCollection 2023.
本文引用的文献
1
The association between glycometabolism and nonalcoholic fatty liver disease in patients with obstructive sleep apnea.
Sleep Breath. 2019 Mar;23(1):373-378. doi: 10.1007/s11325-018-1744-1. Epub 2018 Oct 22.
2
Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea.
J Clin Sleep Med. 2018 Aug 15;14(8):1315-1322. doi: 10.5664/jcsm.7262.
3
Mitochondrial Fatty Acid Oxidation Disorders Associated with Short-Chain Enoyl-CoA Hydratase (ECHS1) Deficiency.
Cells. 2018 May 23;7(6):46. doi: 10.3390/cells7060046.
4
Treating Obstructive Sleep Apnea and Chronic Intermittent Hypoxia Improves the Severity of Nonalcoholic Fatty Liver Disease in Children.
J Pediatr. 2018 Jul;198:67-75.e1. doi: 10.1016/j.jpeds.2018.03.028. Epub 2018 May 8.
5
Association between obstructive sleep apnea and non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Sleep Breath. 2018 Sep;22(3):841-851. doi: 10.1007/s11325-018-1625-7. Epub 2018 Jan 15.
6
Effect of CPAP therapy on liver disease in patients with OSA: a review.
Sleep Breath. 2018 Dec;22(4):963-972. doi: 10.1007/s11325-018-1622-x. Epub 2018 Jan 11.
7
Association between continuous positive airway pressure and serum aminotransferases in patients with obstructive sleep apnea.
Eur Arch Otorhinolaryngol. 2018 Feb;275(2):587-594. doi: 10.1007/s00405-017-4840-0. Epub 2017 Dec 9.
8
Continuous Positive Airway Pressure in Patients With Obstructive Sleep Apnea and Non-Alcoholic Steatohepatitis: A Systematic Review and Meta-Analysis.
J Clin Sleep Med. 2018 Jan 15;14(1):133-139. doi: 10.5664/jcsm.6900.
9
The association of nonalcoholic steatohepatitis and obstructive sleep apnea.
Eur J Gastroenterol Hepatol. 2017 Dec;29(12):1380-1384. doi: 10.1097/MEG.0000000000000973.
10
Projected increase in obesity and non-alcoholic-steatohepatitis-related liver transplantation waitlist additions in the United States.
Hepatology. 2019 Aug;70(2):487-495. doi: 10.1002/hep.29473. Epub 2018 May 14.
Zotero 插件